Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Recent Registrations
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
January
-
February
-
March
-
April
-
May
- June -
July
-
August
-
September
-
Oktober
-
November
-
December
|
2002
- 2003 -
2004
-
2005
-
2006
-
2007
-
2008
-
2009
-
2010
-
2011
-
2012
-
2013
-
2014
-
2015
-
2016
-
2017
-
2018
-
2019
-
2020
-
2021
-
2022
-
2023
-
2024
-
2025
June 2003 - 13 products
IP
CI
Zometa 4 mg/5 ml
Durchstechflasche(n)
165.83
193.10
20 %
Concentrate for infusion: Acidum Zoledronicum 4mg / 5ml
Novartis Pharma
Schweiz AG
B / SL / SO
FB
G
IP
CI
Tramadol Sandoz
10 ml
2.62
12.10
10 %
Solution (oral): Tramadoli Hydrochloridum 100 mg/ml
Sandoz
Pharmaceuticals AG
A / SL / SG
FB
G
IP
CI
Tramadol Sandoz
3 x 10 ml
7.66
17.55
10 %
Solution (oral): Tramadoli Hydrochloridum 100 mg/ml
Sandoz
Pharmaceuticals AG
A / SL / SG
FB
G
IP
CI
Tramadol Sandoz
50 ml
11.20
28.60
10 %
Solution (oral): Tramadoli Hydrochloridum 100 mg/ml
Sandoz
Pharmaceuticals AG
A / SL / SG
FB
G
IP
Epirubicin Sandoz 10 mg/5 ml
Durchstechflasche(n) à 5 ml
17.47
35.40
10 %
Konzentrat zur Herstellung einer Injektionslösung/Instillationslösung: Epirubicini Hydrochloridum 10mg / 5ml
Sandoz
Pharmaceuticals AG
A / SL / SG
FB
G
IP
Epirubicin Sandoz 50
mg/25 ml
Durchstechflasche(n) à 25 ml
65.20
87.30
10 %
Konzentrat zur Herstellung einer Injektionslösung/Instillationslösung: Epirubicini Hydrochloridum 50mg / 25ml
Sandoz
Pharmaceuticals AG
A / SL / SG
FB
G
IP
Epirubicin Sandoz 100
mg/50 ml
Durchstechflasche(n) à 50 ml
111.47
137.65
10 %
Konzentrat zur Herstellung einer Injektionslösung/Instillationslösung: Epirubicini Hydrochloridum 100mg / 50ml
Sandoz
Pharmaceuticals AG
A / SL / SG
FB
G
IP
Epirubicin Sandoz 200
mg/100 ml
Durchstechflasche(n) à 100 ml
184.65
217.25
10 %
Konzentrat zur Herstellung einer Injektionslösung/Instillationslösung: Epirubicini Hydrochloridum 200mg / 100ml
Sandoz
Pharmaceuticals AG
A / SL / SG
FB
G
SIP
IP
CI
Invanz
48.17
68.80
10 %
Lyophilisate: Ertapenemum 1 g
MSD Merck Sharp &
Dohme AG
A / SL
FB
G
IP
CI
Ph
Nasobol Inhalo
‐
I
30 Tablet(s)
PR
PR
k.A.
Effervescent tablets: 4 Active Agents
Spirig HealthCare AG
D / LPPV
FB
G
IP
Beloc i.v.
5 ampoule(s)
PR
PR
k.A.
Injection solution: Metoprololi Tartras 1 mg/ml
Recordati AG
B
FB
G
IP
Zink Biomed 10
50
PR
PR
k.A.
Coated tablets: Zinci D-Gluconas Anhydricus 70 mg
Biomed AG
D
FB
G
IP
CI
Zink Biomed 20
50 Tablet(s)
PR
PR
k.A.
Coated tablets: Zinci D-Gluconas Anhydricus 140 mg
Biomed AG
B
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home